Desheng Weng

Especialidad: Oncólogo clínico
Consultorio: China, Cantón, Sun Yat-sen University Cancer Center (SYSUCC)
Desheng Weng es especialista en el Centro Oncológico de la Universidad Sun Yat-sen, donde se desempeña como profesor asociado y subdirector del Centro de Bioterapia / Oncología Médica de Melanoma y Sarcoma. Su trabajo abarca la genética del cáncer (investigando genes supresores de tumores como ING2, TESTIN, BATF2, LZAP y BIN1 en el carcinoma hepatocelular primario y el cáncer gástrico) y la inmunoterapia contra el cáncer como un enfoque de tratamiento integral. Su enfoque clínico-investigador incluye el melanoma y el sarcoma, junto con la atención oncológica basada en la inmunoterapia.
Desheng Weng es especialista en el Centro Oncológico de la Universidad Sun Yat-sen, donde es profesor asociado y subdirector del Centro de Bioterapia / Oncología Médica de Melanoma y Sarcoma. Combina la investigación en genética del cáncer con la atención oncológica centrada en la inmunoterapia. Su investigación incluye el estudio de genes supresores de tumores como ING2, TESTIN, BATF2, LZAP y BIN1, y sus vínculos con las características clínicas en el carcinoma hepatocelular y el cáncer gástrico.

Servicios médicos

Cribado genético

¿Qué tal su experiencia?

1 de 3

La información sobre este doctor es completa y clara

Totalmente en desacuerdo

Totalmente de acuerdo

Formación académica

Desheng Weng works as a specialist at Sun Yat-sen University Cancer Center, holding the roles of Associate Professor and Deputy Director in the Biotherapy Center and Melanoma and Sarcoma Medical Oncology. His research program connects cancer genetics with immunotherapy, reflecting a biotherapy-centered approach to treating melanoma and sarcoma. In cancer genetics studies, his work includes tumor suppressor gene down-regulation and evaluating genes such as ING2, TESTIN, BATF2, LZAP, and BIN1 in primary hepatocellular carcinoma and gastric cancer. He also investigates how these tumor suppressors relate to clinicopathological parameters and explores their functional roles through in vitro assays such as proliferation, clone formation, motility, invasion, and apoptosis of tumor cell lines. Alongside genetics, Weng’s profile highlights immunotherapy as an important comprehensive method for cancer patients. For international patients, this means he participates in a program where treatment planning is informed by both tumor biology and immunotherapy concepts.

Education

Education details are not specified in the provided profile materials.

Work experience

Associate Professor and Deputy Director, Biotherapy Center / Melanoma and Sarcoma Medical Oncology, Sun Yat-sen University Cancer Center (current role).

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Desheng Weng’s clinical-research focus centers on immunotherapy and biotherapy for melanoma and sarcoma, supported by cancer genetics work.

Cancer immunotherapy as a comprehensive treatment approach.
Cancer genetics research, including tumor suppressor gene expression studies (ING2, TESTIN, BATF2, LZAP, BIN1).
Functional evaluation using in vitro proliferation, clone formation, motility, invasion, and apoptosis assays.

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

Publication and citation metrics are not specified in the provided profile materials.

Courses and advanced training

Courses and advanced training are not specified in the provided profile materials.

Awards and recognition

Awards are not specified in the provided profile materials.

Desheng Weng’s role at Sun Yat-sen University Cancer Center places him within a biotherapy and immunotherapy environment for melanoma and sarcoma. The profile materials do not specify spoken languages.